IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement
August 12, 2022 09:16 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 12, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Completes Walmart Pilot Program, Affirms Commitment to Growth
April 07, 2022 08:47 ET
|
IMAC Holdings, Inc.
The Company plans to add 20 locations in the next 12 months BRENTWOOD, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the...
IMAC Holdings, Inc. Announces Completion of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
February 16, 2022 09:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for...
IMAC Holdings Expands into Louisiana with Baton Rouge Orthopedic Business
October 04, 2021 09:30 ET
|
IMAC Holdings, Inc.
Allen Johnston, M.D. Joins IMAC as a Medical Director, Expanding Company’s Footprint, Expertise in Sports Medicine BRENTWOOD, Tenn, Oct. 04, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings,...
IMAC Holdings, Inc. Announces Initiation of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
July 13, 2021 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, July 13, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has initiated the second cohort of its Phase 1 clinical trial for...
IMAC Holdings Appoints Sheri Gardzina as Secretary, Chief Financial Officer
January 07, 2021 08:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease
December 30, 2020 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Dec. 30, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 30, 2020 16:05 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, Nov. 30, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. To Participate in the Virtual Fall Investor Summit on November 16-18, 2020
November 13, 2020 08:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, Nov. 13, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...